Particle size characterization in nanosuspensions often focuses on ‘majority’ features of the size distribution. Yet, for various suspensions in (bio)pharmaceuticals or fine chemicals, small fractions ...

Malvern Panalytical’s recent peer-reviewed publication, Tailoring Lipid Nanoparticle Dimensions Through Manufacturing Processes, published in RSC Pharmaceutics, features both the NanoSight Pro ...

From vaccines to personalized cancer therapies, scientists are studying the use of mRNA across many clinical applications. However, there are several factors that are unique to mRNA drug product ...

Nanobiotechnology is driving a new era in the life sciences, where the intersection of engineered nanomaterials and biology is catalyzing major advances in ...

As Sujan Manna searched for tiny, spherical gold nanoparticles against a dark-field backdrop, he came across an unexpected ...

Liposomes and lipid nanoparticles (LNPs) are versatile drug delivery systems that allow precise control over composition, morphology, and structure, tailoring these features to meet specific ...

The unique behavior of nanoparticles is driven by their size, surface structure, and interaction dynamics, all of which must be measured and characterized with high precision. Nanoparticles interact, ...

Spatially Resolved Dynamic Light Scattering (SR-DLS) is an established technique for efficient nanoparticle size characterization for inline Process Analytical Technology as well as for at/off-line ...

A crucial element in both the synthesis and functionality of nanoparticles involves the attachment of ligands. 6 The appropriate choice of ligands can enhance the solubility of nanoparticles or affect ...

Nanoparticle mRNA Therapeutics has been the focus of intense research driven by the safety profile and several clinical breakthroughs. As of March 2024, there are two mRNA vaccines approved and many ...